blank Quick help
blank Maintenance news

Scheduled maintenance

Regular maintenance outages:
between 05.00 and 05.15 hrs CET (Monday to Sunday).

Other outages
Availability
Register Forum

2022.02.11

More...
blank News flashes

News flashes

New version of the European Patent Register - SPC information for Unitary Patents.

2024-03-06

More...
blank Related links

Extract from the Register of European Patents

EP About this file: EP0383361

EP0383361 - 1-Beta-D-Ribofuranosyl-1,2,4-triazole-3-carboxamide for use in medical treatment of humans [Right-click to bookmark this link]
StatusThe application is deemed to be withdrawn
Status updated on  11.10.1996
Database last updated on 15.06.2024
Most recent event   Tooltip11.10.1996Application deemed to be withdrawnpublished on 27.11.1996 [1996/48]
Applicant(s)For all designated states
VIRATEK, INC.
3300 Hyland Avenue Costa Mesa
California 92626 / US
[N/P]
Former [1990/34]For all designated states
VIRATEK, INC.
3300 Hyland Avenue
Costa Mesa California 92626 / US
Inventor(s)01 / Smith, Robert Angus
221, 17th Street
Santa Monica, California 90402 / US
02 / Fernandez, Humberto
3571 Myrtle Street
Irvine, California 92714 / US
[1990/34]
Representative(s)Goldin, Douglas Michael, et al
J.A. KEMP & CO. 14 South Square Gray's Inn
London WC1R 5JJ / GB
[N/P]
Former [1990/34]Goldin, Douglas Michael, et al
J.A. KEMP & CO. 14, South Square Gray's Inn
London WC1R 5LX / GB
Application number, filing date90105678.816.04.1985
[1990/34]
Priority number, dateUS1984066625229.10.1984         Original published format: US 666252
[1990/34]
Filing languageEN
Procedural languageEN
PublicationType: A2 Application without search report 
No.:EP0383361
Date:22.08.1990
Language:EN
[1990/34]
Type: A3 Search report 
No.:EP0383361
Date:16.06.1993
Language:EN
[1993/24]
Search report(s)(Supplementary) European search report - dispatched on:EP26.04.1993
ClassificationIPC:A61K31/70
[1990/34]
CPC:
A61K31/7004 (EP); A61K31/41 (KR); A61P11/00 (EP);
A61P31/12 (EP); C07H19/056 (EP)
Designated contracting statesAT,   CH,   DE,   FR,   GB,   IT,   LI,   NL,   SE [1990/34]
TitleGerman:1-Beta-D-ribofuranosyl-1,2,4-triazol-3-carboxamid für die Verwendung bei der medizinischen Behandlung von Menschen[1990/34]
English:1-Beta-D-Ribofuranosyl-1,2,4-triazole-3-carboxamide for use in medical treatment of humans[1990/34]
French:1-Bêta-D-ribofuranosyl-1,2,4-triazole-3-carboxamide pour l'emploi dans le traitement médical d'humains[1990/34]
File destroyed:20.04.2002
MiscellaneousEPB 1995/07: Teilanmeldung 94118300.6 eingereicht am 16/04/85
EPB 1995/07: Divisional application 94118300.6 filed on 16/04/85
EPB 1995/07: Demande divisionnaire 94118300.6 déposée le 16/04/85
Examination procedure26.03.1990Examination requested  [1990/34]
11.05.1994Despatch of a communication from the examining division (Time limit: M06)
27.04.1995Reply to a communication from the examining division
20.10.1995Despatch of a communication from the examining division (Time limit: M06)
01.05.1996Application deemed to be withdrawn, date of legal effect  [1996/48]
28.06.1996Despatch of communication that the application is deemed to be withdrawn, reason: reply to the communication from the examining division not received in time  [1996/48]
Parent application(s)   TooltipEP85302644.1  / EP0181050
Divisional application(s)EP94118300.6  / EP0643970
Request for further processing for:27.04.1995Request for further processing filed
27.04.1995Full payment received (date of receipt of payment)
Request granted
15.05.1995Decision despatched
Fees paidRenewal fee
26.03.1990Renewal fee patent year 03
26.03.1990Renewal fee patent year 04
26.03.1990Renewal fee patent year 05
26.03.1990Renewal fee patent year 06
18.09.1991Renewal fee patent year 07
25.09.1992Renewal fee patent year 08
15.03.1993Renewal fee patent year 09
14.04.1994Renewal fee patent year 10
13.04.1995Renewal fee patent year 11
09.04.1996Renewal fee patent year 12
Penalty fee
Additional fee for renewal fee
02.05.199107   M06   Fee paid on   18.09.1991
04.05.199208   M06   Fee paid on   25.09.1992
Opt-out from the exclusive  Tooltip
competence of the Unified
Patent Court
See the Register of the Unified Patent Court for opt-out data
Responsibility for the accuracy, completeness or quality of the data displayed under the link provided lies entirely with the Unified Patent Court.
Documents cited:Search[X]  - ANTIVIRAL RES., vol. 1, no. 1, March 1981, pages 47-53, Elsevier/North-Holland Biomedical Press; R.W. SIDWELL et al.: "Bovine leukemia virus inhibition in vitro by ribavirin"
 [X]  - PROCEEDINGS OF THE SOCIETY FOR EXPERIMENTAL BIOLOGY AND MEDICINE, vol. 148, no. 3, March 1975, pages 854-858, The Society for Experimental Biology and Medicine; R.W. SIDWELL et al.: "Effect of 1-beta-D-ribofuranosyl-1,2,4-triazole-3-carboxamide (ribavirin) on friend leukemia virus infections in mice (38647)"
 [X]  - ARCHIVES INTERNATIONALES DE PHYSIOLOGIE ET DE BIOCHIMIE, vol. 87, no. 2, May 1979, pages 353-395; E. DE CLERCQ: "New trends in antiviral chemotherapy"
 [X]  - ANTIBIOTICS CHEMOTHER., vol. 27, 1980, pages 208-232; R.W. SIDWELL et al.: "5-Membered azaheterocycles and their nucleosides"
 [X]  - ADVANCES IN COMPARATIVE LEUKEMIA RESEARCH, PROC. INT. SYMP., 9th, (ed. D.S. YOHN), (Elsevier, Amsterdam, NL), 1980, pages 123-124; Y.C. CHEN et al.: "Effects of 3-deazaguanine and virazole on rous sarcoma viruses"
 [X]  - DRUGS, vol. 22, no. 2, August 1981, pages 111-128, ADIS Press Australasia Pty Ltd; T.-W. CHANG et al.: "Ribavirin and inosiplex: a review of their present status in viral diseases"
 [XP]  - LANCET, vol. 2, no. 8416, 15th December 1984, pages 1367-1369; J.B. McCORMICK et al.: "Ribavirin suppresses replication of lymphadenopathy-associated virus in cultures of human adult T lymphocytes"
The EPO accepts no responsibility for the accuracy of data originating from other authorities; in particular, it does not guarantee that it is complete, up to date or fit for specific purposes.